Q2 Results Update, Oct. 22 -- Maharatna oil PSU Bharat Petroleum Corporation Ltd (BPCL) on Wednesday, 22 October 2025, disclosed that the board of directors has finalised the date to hold its quarterl... Read More
India-US trade deal, Oct. 22 -- After a gruelling few months, the Indian stock market has found its mojo back. And with the possibility of an India-US trade deal looming, analysts believe the "sky is ... Read More
Mumbai, Oct. 22 -- Nagpur-based non-banking financial company Berar Finance Ltd has raised Rs.150 crore in a funding round led by Norwegian fund Abler Nordic and First Bridge India Growth Fund, while ... Read More
New Delhi, Oct. 22 -- For the average borrower, the idea of a credit report often carries an air of complexity. Many only encounter it when applying for a loan, usually at a critical juncture, like fi... Read More
New Delhi, Oct. 22 -- Apple's new Visited Places feature in iOS 26 sounds useful, but it's raising questions about privacy. The good news: it's not automatic. You have to turn it on yourself. The bad ... Read More
New Delhi, Oct. 22 -- The camera in your pocket has more power than you realise. Most Android phones now ship with incredible sensors yet the stock camera app rarely lets you dive into full manual con... Read More
New Delhi, Oct. 22 -- US return man, who moved back to India 5 years ago, reflected on the benefits of staying in home country. Leaving behind the 'H1B grind,' he asserted that if one finds satisfacto... Read More
New Delhi, Oct. 22 -- Singer Lucky Ali attacked Javed Akhtar on social media after a post highlighted the veteran lyricist and screenwriter's thoughts as he told Hindus not to 'become like Muslims.' I... Read More
New Delhi, Oct. 22 -- On a humid afternoon in Mumbai, 68-year-old Usha Nair, a retired teacher sat with her daughter, staring blankly at the steaming cup of tea placed in front of her. "Did you make t... Read More
New Delhi, Oct. 22 -- Biocon Biologics Ltd is aiming to expand its insulin portfolio in the US market, as global innovators focus on more lucrative anti-obesity GLP-1 therapies. Biocon Ltd's biosimil... Read More